Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia

Human Molecular Genetics

Volumn 21, Issue 22, 2012, Pages 4910-4921

  Winchester, Catherine L ^a,c   Ohzeki, Hiromitsu ^a,d   Vouyiouklis, Demetrius A ^a,b   Thompson, Rhiannon ^a,b   Penninger, Josef M ^e   Yamagami, Keiji ^a,d   Norrie, John D ^a,g   Hunter, Robert ^a,f   Pratt, Judith A ^a,c   Morris, Brian J ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^e UNIVERSITY OF VIENNA   (Austria)

^f GARTNAVEL ROYAL HOSPITAL   (United Kingdom)

^g UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; AUTOPSY; BEHAVIOR; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EXON; GENE DOSAGE; GENE EXPRESSION; GENE REPLICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLASGOW COMA SCALE; HAPLOTYPE; HUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; WORKING MEMORY;

ALLELES; ANIMALS; CASE-CONTROL STUDIES; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MAP KINASE KINASE 7; MICE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; SCHIZOPHRENIA;

MUS;

EID: 84868094765     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds331     Document Type: Article

References (88)

1. Sun, J., Kuo, P.-H., Kendler, K.S. and Zhao, Z. (2008) Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am. J. Med. Genet. B Neuropsychiatr. Genet., 147B, 1173-1181.
2. Williams, H.J., Owen, M.J. and O'Donovan, M.C. (2009) New findings from genetic association studies of schizophrenia. J. Hum. Genet., 54, 9-14.
3. Shi, J., Levinson, D.F., Duan, J., Sanders, A.R., Zheng, Y., Pe'er, I., Dudbridge, F., Holmans, P.A., Whittemore, A.S., Mowry, B.J. et al. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature, 460, 753-757.
4. Yue, W.-H., Wang, H.-F., Sun, L.-D., Tang, F.-L., Liu, Z.-H., Zhang, H.-X., Li, W.-Q., Zhang, Y.-L., Zhang, Y., Ma, C.-C. et al. (2011) Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat. Genet., 43, 1228-1231.
5. Ripke, S. and Consortium, S.P.G.-W.A.S.G. (2011) Genome-wide association study identifies five new schizophrenia loci. Nat. Genet., 43, 969-976.
6. Vacic, V., McCarthy, S., Malhotra, D., Murray, F., Chou, H.-H., Peoples, A., Makarov, V., Yoon, S., Bhandari, A., Corominas, R. et al. (2011) Duplications of the neuropeptide receptor gene Vipr2 confer significant risk for schizophrenia. Nature, 471, 499-503.
7. Tamminga, C.A., Thaker, G.K., Buchanan, R., Kirkpatrick, B., Alphs, L.D., Chase, T.N. and Carpenter, W.T. (1992) Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch. Gen. Psychiatry, 49, 522-530.
8. Hill, K., Mann, L., Laws, K.R., Stephenson, C.M., Nimmo-Smith, I. and McKenna, P.J. (2004) Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr. Scand., 110, 243-256.
9. Molina, V., Sanz, J., Reig, S., Martinez, R., Sarramea, F., Luque, R., Benito, C., Gispert, J.D., Pascau, J. and Desco, M. (2005) Hypofrontality in men with first-episode psychosis. Br. J. Psychiatry, 186, 203-208.
10. Gonzalez-Burgos, G., Fish, K.N. and Lewis, D.A. (2011) Gaba neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast, 2011. Article ID 723184
11. Beasley, C.L. and Reynolds, G.P. (1997) Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res., 24, 349-355.
12. Keshavan, M.S., Tandon, R., Boutros, N.N. and Nasrallah, H.A. (2008) Schizophrenia, 'Just the Facts': what we know in 2008: Part 3: neurobiology. Schizophr. Res., 106, 89-107.
13. Ortiz-Gil, J., Pomarol-Clotet, E., Salvador, R., Canales-Rodriguez, E.J., Sarró, S., Gomar, J.J., Guerrero, A., Sans-Sansa, B., Capdevila, A., Junqué, C. et al. (2012) Neural correlates of cognitive impairment in schizophrenia. Br. J. Psychiatry, 199, 202-210.
14. Perlstein, W.M., Carter, C.S., Noll, D.C. and Cohen, J.D. (2001) Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am. J. Psychiatry, 158, 1105-1113.
15. van Veelen, N.M.J., Vink, M., Ramsey, N.F. and Kahn, R.S. (2010) Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia. Schizophr. Res., 123, 22-29.
16. Potkin, S.G., Alva, G., Fleming, K., Anand, R., Keator, D., Carreon, D., Doo, M., Jin, Y., Wu, J.C. and Fallon, J.H. (2002) A pet study of the pathophysiology of negative symptoms in schizophrenia. Am. J. Psychiatry, 159, 227-237.
17. Murray, J.B. (2002) Phencyclidine (Pcp): a dangerous drug, but useful in schizophrenia research. J. Psychol., 136, 319-327.
18. Morris, B.J., Cochran, S.M. and Pratt, J.A. (2005) Pcp: from pharmacology to modelling schizophrenia. Curr. Opin. Pharmacol., 5, 1-6.
19. Cochran, S.M., Steward, L.J., Kennedy, M.B., McKerchar, C.E., Pratt, J.A. and Morris, B.J. (2003) Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology, 28, 265-275.
20. Lewis, C.M., Baldassarre, A., Committeri, G., Romani, G.L. and Corbetta, M. (2009) Learning sculpts the spontaneous activity of the resting human brain. Proc. Natl Acad. Sci. USA, 106, 17558-17575.
21. Canals, S., Beyerlein, M., Merkle, H. and Logothetis, N.K. (2009) Functional Mri evidence for Ltp-induced neural network reorganization. Curr. Biol., 19, 398-403.
22. Haracz, J.L. (1985) Neural plasticity in schizophrenia. Schizophr. Bull., 11, 191-229.
23. Stephan, K.E., Friston, K.J. and Frith, C.D. (2009) Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr. Bull., 35, 509-527.
24. Goto, Y., Yang, C.R. and Otani, S. (2010) Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biol. Psychiatry, 67, 199-207.
25. Morris, B.J. (2004) Neuronal plasticity. In Davies, R.W. and Morris, B.J. (eds.), Molecular Biology of the Neuron. Oxford University Press, Oxford, UK, pp. 357-386.
26. Bentires-Alj, M., Kontaridis, M.I. and Neel, B.G. (2006) Stops along the ras pathway in human genetic disease. Nat. Med., 12, 283-285.
27. Zhu, Y., Pak, D., Qin, Y., McCormack, S.G., Kim, M.J., Baumgart, J.P., Velamoor, V., Auberson, Y.P., Osten, P., van Aelst, L. et al. (2005) Rap2-Jnk removes synaptic AMPA receptors during depotentiation. Neuron, 46, 905-916.
28. Toyoda, H., Zhao, M.-G., Xu, H., Wu, L.-J., Ren, M. and Zhuo, M. (2007) Requirement of extracellular signal-regulated kinase/mitogen-activated protein kinase for long-term potentiation in adult mouse anterior cingulate cortex. Mol. Pain, 3, 36.
29. Chen, J.-T., Lu, D.-H., Chia, C.-P., Ruan, D.-Y., Sabapathy, K. and Xiao, Z.-C. (2005) Impaired long-term potentiation in C-Jun N-Terminal kinase 2-Deficient mice. J. Neurochem., 93, 463-473.
30. Yang, H., Courtney, M.J., Martinsson, P. and Manahan-Vaughan, D. (2011) Hippocampal long-term depression is enhanced, depotentiation is inhibited and long-term potentiation is unaffected by the application of a selective C-Jun N-Terminal kinase inhibitor to freely behaving rats. Eur. J. Neurosci., 33, 1647-1655.
31. Li, X.-M., Li, C.-C., Yu, S.-S., Chen, J.-T., Sabapathy, K. and Ruan, D.-Y. (2007) Jnk1 contributes to metabotropic glutamate receptor-dependent long-term depression and short-term synaptic plasticity in the mice area hippocampal ca1. Eur. J. Neurosci., 25, 391-396.
32. Centeno, C., Repici, M., Chatton, J.Y., Riederer, B.M., Bonny, C., Nicod, P., Price, M., Clarke, P.G.H., Papa, S., Franzoso, G. et al. (2006) Role of the Jnk pathway in nmda-mediated excitotoxicity of cortical neurons. Cell Death Differ., 14, 240-253.
33. Hatcher, J.P., Jones, D.N.C., Rogers, D.C., Hatcher, P.D., Reavill, C., Hagan, J.J. and Hunter, A.J. (2001) Development of shirpa to characterise the phenotype of gene-targeted mice. Behav. Brain Res., 125, 43-47.
34. Aultman, J.M. and Moghaddam, B. (2001) Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacology (Berl), 153, 353-364.
35. Pimm, J., McQuillin, A., Thirumalai, S., Lawrence, J., Quested, D., Bass, N., Lamb, G., Moorey, H., Datta, S.R., Kalsi, G. et al. (2005) The Epsin 4 gene on chromosome 5q, which encodes the clathrin-associated protein enthoprotin, is involved in the genetic susceptibility to schizophrenia. Am. J. Hum. Genet., 76, 902-907.
36. International, S.C. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460, 748-752.
37. Tournier, C., Whitmarsh, A.J., Cavanagh, J., Barrett, T. and Davis, R.J. (1999) The Mkk7 gene encodes a group of C-Jun Nh2-Terminal kinase kinases. Mol. Cell. Biol., 19, 1569-1581.
38. Bray, N.J., Buckland, P.R., Owen, M.J. and O'Donovan, M.C. (2003) Cis-acting variation in the expression of a high proportion of genes in human brain. Hum. Genet., 113, 149-153.
39. Yang, G. and Cynader, M.S. (2011) Palmitoyl acyltransferase Zd17 mediates neuronal responses in acute ischemic brain injury by regulating Jnk activation in a signaling module. J. Neurosci., 31, 11980-11991.
40. Moriguchi, T., Toyoshima, F., Masuyama, N., Hanafusa, H., Gotoh, Y. and Nishida, E. (1997) A novel Sapk/Jnk kinase, Mkk7, stimulated by Tnfa and cellular stresses. EMBO J., 16, 7045-7053.
41. Coffey, E.T., Hongisto, V., Dickens, M., Davis, R.J. and Courtney, M.J. (2000) Dual roles for C-Jun N-Terminal kinase in developmental and stress responses in cerebellar granule neurons. J. Neurosci., 20, 7602-7613.
42. Lewis, D.A., Pierri, J.N., Volk, D.W., Melchitzky, D.S. and Woo, T.U. (1999) Altered gaba neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol. Psychiatry, 46, 616-626.
43. Kishimoto, H., Nakagawa, K., Watanabe, T., Kitagawa, D., Momose, H., Seo, J., Nishitai, G., Shimizu, N., Ohata, S., Tanemura, S. et al. (2003) Different properties of Sek1 and Mkk7 in dual phosphorylation of stress-induced activated protein kinase Sapk/Jnk in embryonic stem cells. J. Biol. Chem., 278, 16595-16601.
44. Sasaki, T., Wada, T., Kishimoto, H., Irie-Sasaki, J., Matsumoto, G., Goto, T., Yao, Z., Wakeham, A., Mak, T.W., Suzuki, A. et al. (2001) The stress kinase mitogen-activated protein kinase kinase (Mkk)7 is a negative regulator of antigen receptor and growth factor receptor-induced proliferation in hematopoietic cells. J. Exp. Med., 194, 757-768.
45. Perry, W., Heaton, R.K., Potterat, E., Roebuck, T., Minassian, A. and Braff, D.L. (2001) Working memory in schizophrenia: transient storage versus executive functioning. Schizophr. Bull., 27, 157-176.
46. Kuperberg, G. and Heckers, S. (2000) Schizophrenia and cognitive function. Curr. Opin. Neurobiol., 10, 205-210.
47. Green, M.F. (2006) Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J. Clin. Psychiatry, 67, e12.
48. Crider, A. (1997) Perseveration in schizophrenia. Schizophr. Bull., 23, 63-74.
49. Hazlett, E.A., Buchsbaum, M.S., Jeu, L.A., Nenadic, I., Fleischman, M.B., Shihabuddin, L., Haznedar, M.M. and Harvey, P.D. (2000) Hypofrontality in unmedicated schizophrenia patients studied with pet during performance of a serial verbal learning task. Schizophr. Res., 43, 33-46.
50. Clapcote, S.J., Lipina, T.V., Millar, J.K., Mackie, S., Christie, S., Ogawa, F., Lerch, J.P., Trimble, K., Uchiyama, M., Sakuraba, Y. et al. (2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron, 54, 387-402.
51. Koike, H., Arguello, P.A., Kvajo, M., Karayiorgou, M. and Gogos, J.A. (2006) Disc1 is mutated in the 129s6/Svev strain and modulates working memory in mice. Proc. Natl Acad. Sci. USA, 103, 3693-3697.
52. Chanock, S.J., Manolio, T., Boehnke, M., Boerwinkle, E., Hunter, D.J., Thomas, G., Hirschhorn, J.N., Abecasis, G., Altshuler, D., Bailey-Wilson, J.E. et al. (2007) Replicating genotype-phenotype associations. Nature, 447, 655-660.
53. Hamshere, M.L., Bennett, P., Williams, N., Segurado, R., Cardno, A., Norton, N., Lambert, D., Williams, H., Kirov, G., Corvin, A. et al. (2005) Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to Disc1, and suggestive evidence at 22q11 and 19p13. Arch. Gen. Psychiatry, 62, 1081-1088.
54. Kaufmann, C.A., Suarez, B., Malaspina, D., Pepple, J., Svrakic, D., Markel, P.D., Meyer, P.D., Zambuto, C.T., Schmitt, K., Matise, T.C. et al. (1998) Nimh genetics initiative millennium schizophrenia consortium: linkage analysis of African-American pedigrees. Am. J. Med. Genet., 81, 282-289.
55. Chodirker, B.N., Chudley, A.E., Ray, M., Wickstrom, D.E. and Riordan, D.L. (1987) Fragile 19p13 in a family with mental illness. Clin. Genet., 31, 1-6.
56. Bassett, A.S., Costain, G., Alan Fung, W.L., Russell, K.J., Pierce, L., Kapadia, R., Carter, R.F., Chow, E.W.C. and Forsythe, P.J. (2010) Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. J. Psychiatr. Res., 44, 1005-1009.
57. Harr, B., Voolstra, C, Heinen, T., Baines, J., Rottscheidt, R., Ihle, S., Müller, W., Bonhomme, F. and Tautz, D. (2006) A change of expression in the conserved signaling gene Mkk7 is associated with a selective sweep in the Western house mouse mus musculus domesticus. J. Evol. Biol., 19, 1486-1496.
58. Pritchard, J.K. (2001) Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Gen., 69, 124-137.
59. Heinzen, E.L., Ge, D., Cronin, K.D., Maia, J.M., Shianna, K.V., Gabriel, W.N., Welsh-Bohmer, K.A., Hulette, C.M., Denny, T.N. and Goldstein, D.B. (2008) Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol., 6, e1000001.
60. Haeusgen, W., Herdegen, T. and Waetzig, V. (2010) Specific regulation of Jnk signalling by the novel rat Mkk7g1 isoform. Cell. Signal., 22, 1761-1772.
61. Wada, T., Nakagawa, K., Watanabe, T., Nishitai, G., Seo, J., Kishimoto, H., Kitagawa, D., Sasaki, T., Penninger, J.M., Nishina, H. et al. (2001) Impaired synergistic activation of stress-activated protein kinase Sapk/Jnk in mouse embryonic stem cells lacking Sek1/Mkk4. J. Biol. Chem., 276, 30892-30897.
62. Haeusgen, W., Herdegen, T. and Waetzig, V. (2011) Mkk7g1 reverses nerve growth factor signals: proliferation and cell death instead of neuritogenesis and protection. Cell. Signal., 23, 1281-1290.
63. Nakagawa, K., Sugahara, M., Yamasaki, T., Kajiho, H., Takahashi, S., Hirayama, J., Minami, Y., Ohta, Y., Watanabe, T., Hata, Y. et al. (2010) Filamin associates with stress signalling kinases Mkk7 and Mkk4 and regulates Jnk activation. Biochem. J., 427, 237-245.
64. Sutton, L.P., Honardoust, D., Mouyal, J., Rajakumar, N. and Rushlow, W.J. (2007) Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3. J. Neurochem., 102, 153-169.
65. Browning, J.L., Patel, T., Brandt, P.C., Young, K.A., Holcomb, L.A. and Hicks, P.B. (2005) Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions. Biol. Psychiatry, 57, 617-623.
66. Courtois-Cox, S., Genther Williams, S.M., Reczek, E.E., Johnson, B.W., McGillicuddy, L.T., Johannessen, C.M., Hollstein, P.E., MacCollin, M. and Cichowski, K. (2006) A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell, 10, 459-472.
67. Sherrin, T., Blank, T., Hippel, C., Rayner, M., Davis, R.J. and Todorovic, C. (2010) Hippocampal C-Jun-N-Terminal kinases serve as negative regulators of associative learning. J. Neurosci., 30, 13348-13361.
68. Nijboer, C.H., Heijnen, C.J., Groenendaal, F., van Bel, F. and Kavelaars, A. (2009) Alternate pathways preserve tumor necrosis factor-{Alpha} production after nuclear factor-{Kappa}B inhibition in neonatal cerebral hypoxia-ischemia. Stroke, 40, 3362-3368.
69. Chen, X., Tian, Y., Yao, L., Zhang, J. and Liu, Y. (2010) Hypoxia stimulates proliferation of rat neural stem cells with influence on the expression of cyclin D1 and C-Jun N-Terminal protein kinase signaling pathway in vitro. Neuroscience, 165, 705-714.
70. Chaveroux, C., Jousse, C., Cherasse, Y., Maurin, A.-C., Parry, L., Carraro, V., Derijard, B., Bruhat, A. and Fafournoux, P. (2009) Identification of a novel amino acid response pathway triggering Atf2 phosphorylation in mammals. Mol. Cell. Biol., 29, 6516-6526.
71. Tandon, R., Keshavan, M.S. and Nasrallah, H.A. (2008) Schizophrenia, 'Just the Facts' what we know in 2008. 2. Epidemiology and etiology. Schizophr. Res., 102, 1-18.
72. Wajant, H., Pfizenmaier, K. and Scheurich, P. (2003) Tumor necrosis factor signaling. Cell Death Differ., 10, 45-65.
73. Schwarzschild, M.A., Cole, R.L. and Hyman, S.E. (1997) Glutamate, but not dopamine, stimulates stress-activated protein kinase and Ap-1-Mediated transcription in striatal neurons. J. Neurosci., 17, 3455-3466.
74. Ko, H.W., Park, K.Y., Kim, H., Han, P.L., Kim, Y.C., Gwag, B.J. and Choi, E.J. (1998) Ca2+-mediated activation of C-Jun N-Terminal kinase and nuclear factor kappa B by Nmda in cortical cell cultures. J. Neurochem., 71, 1390-1395.
75. Hussain, N.K., Hsin, H., Huganir, R.L. and Sheng, M. (2010) Mink and Tnik differentially act on Rap2-mediated signal transduction to regulate neuronal structure and ampa receptor function. J. Neurosci., 30, 14786-14794.
76. Wang, Q., Charych, E.I., Pulito, V.L., Lee, J.B., Graziane, N.M., Crozier, R.A., Revilla-Sanchez, R., Kelly, M.P., Dunlop, A.J., Murdoch, H. et al. (2010) The psychiatric disease risk factors Disc1 and Tnik interact to regulate synapse composition and function. Mol. Psychiatry, 16, 1006-1023.
77. Potkin, S.G., Turner, J.A., Guffanti, G., Lakatos, A., Fallon, J.H., Nguyen, D.D., Mathalon, D., Ford, J., Lauriello, J., Macciardi, F. et al. (2009) A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr. Bull., 35, 96-108.
78. Funk, A.J., McCullumsmith, R.E., Haroutunian, V. and Meador-Woodruff, J.H. (2011) Abnormal activity of the Mapk- and camp-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia. Neuropsychopharmacology, 37, 896-905.
79. Jaaro-Peled, H., Hayashi-Takagi, A., Seshadri, S., Kamiya, A., Brandon, N.J. and Sawa, A. (2009) Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through Neuregulin-1-Erbb4 and Disc1. Trends Neurosci. 32, 485-495.
80. Kuan, C.-Y., Yang, D.D., Roy, D.R.S., Davis, R.J., Rakic, P. and Flavell, R.A. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron, 22, 667-676.
81. Asaoka, Y. and Nishina, H. (2010) Diverse physiological functions of Mkk4 and Mkk7 during early embryogenesis. J. Biochem., 148, 393-401.
82. Yamasaki, T., Kawasaki, H., Arakawa, S., Shimizu, K., Shimizu, S., Reiner, O., Okano, H., Nishina, S., Azuma, N., Penninger, J.M. et al. (2011) Stress-activated protein kinase Mkk7 regulates axon elongation in the developing cerebral cortex. J. Neurosci., 31, 16872-16883.
83. Gough, S.C.L. and O'Donovan, M.C. (2005) Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J. Psychopharmacol., 19, 47-55.
84. Leucht, S., Burkard, T., Henderson, J., Maj, M. and Sartorius, N. (2007) Physical illness and schizophrenia: a review of the literature. Acta Psychiatr. Scand., 116, 317-333.
85. Spelman, L.M., Walsh, P.I., Sharifi, N., Collins, P. and Thakore, J.H. (2007) Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia. Diabet. Med., 24, 481-485.
86. Holt, R.I.G., Bushe, C. and Citrome, L. (2005) Diabetes and schizophrenia 2005: are we any closer to understanding the link? J. Psychopharmacol., 19, 56-65.
87. Jaeschke, A., Rincón, M., Doran, B., Reilly, J., Neuberg, D., Greiner, D.L., Shultz, L.D., Rossini, A.A., Flavell, R.A. and Davis, R.J. (2005) Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of Type I diabetes. Proc. Natl Acad. Sci. USA, 102, 6931-6935.
88. Akhurst, R.J. (2012) The paradoxical TGF-b vasculopathies. Nat. Genet., 44, 838-839.